SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-17-003386
Filing Date
2017-01-20
Accepted
2017-01-20 17:28:15
Documents
73
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A a16-22703_110qa.htm 10-Q/A 1388416
2 EX-31.1 a16-22703_1ex31d1.htm EX-31.1 10680
3 EX-31.2 a16-22703_1ex31d2.htm EX-31.2 10750
4 EX-32.1 a16-22703_1ex32d1.htm EX-32.1 6759
5 EX-32.2 a16-22703_1ex32d2.htm EX-32.2 6786
  Complete submission text file 0001104659-17-003386.txt   6770190

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20160331.xml EX-101.INS 1736383
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20160331.xsd EX-101.SCH 42769
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20160331_cal.xml EX-101.CAL 65520
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20160331_def.xml EX-101.DEF 134544
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20160331_lab.xml EX-101.LAB 415777
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20160331_pre.xml EX-101.PRE 304203
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q/A | Act: 34 | File No.: 001-35518 | Film No.: 17539347
SIC: 2834 Pharmaceutical Preparations